Leucocyte glucose-6-phosphate dehydrogenase (g-6-pd) activity in g-6-pd deficient subjects. 1980

F Tzortzatou-Stathopoulou, and L Zannos-Mariolea, and P Karayiannis, and N Constantsas, and N Matsaniotis

The activity of glucose-6-phosphate dehydrogenase (G-6-PD) in leucocytes was studied in the following group of Greek people. Group 1: 43 male children and 16 male students with mean values of enzyme activity of 27.7 +/- 16.6 units and 24.6 +/- 5.6 units, respectively. Group 2: 15 G-6-PD deficient male children who had never experienced an acute haemolytic episode with a mean value of 10.8 +/- 4.6 units. Group 3: 19 G-6-PD deficient male children during favism and 3 months after the haemolytic crisis with mean values of 8 +/- 4 units and 9.2 +/- 1.9 units, respectively. Group 4: 19 mothers of children from group 3 who by definition were carriers of G-6-PD deficiency had a mean value of 18.2 +/- 8.2 units. The difference between means for group 1 and groups 2, 3 and 4 is highly significant (P < 0.001). Therefore the enzymatic defect in Greek people is not limited to the erythrocytes but can be also demonstrated in leucocytes.

UI MeSH Term Description Entries
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005236 Favism Hemolytic anemia due to the ingestion of fava beans or after inhalation of pollen from the Vicia fava plant by persons with glucose-6-phosphate dehydrogenase deficient erythrocytes. Favisms
D005260 Female Females
D005954 Glucosephosphate Dehydrogenase Glucose-6-Phosphate Dehydrogenase,Dehydrogenase, Glucose-6-Phosphate,Dehydrogenase, Glucosephosphate,Glucose 6 Phosphate Dehydrogenase
D005955 Glucosephosphate Dehydrogenase Deficiency A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia. Deficiency of Glucose-6-Phosphate Dehydrogenase,Deficiency, GPD,Deficiency, Glucosephosphate Dehydrogenase,G6PD Deficiency,GPD Deficiency,Glucose 6 Phosphate Dehydrogenase Deficiency,Glucose-6-Phosphate Dehydrogenase Deficiency,Glucosephosphate Dehydrogenase Deficiencies,Hemolytic Anemia Due to G6PD Deficiency,Deficiencies, G6PD,Deficiencies, GPD,Deficiencies, Glucose-6-Phosphate Dehydrogenase,Deficiencies, Glucosephosphate Dehydrogenase,Deficiency of Glucose 6 Phosphate Dehydrogenase,Deficiency, G6PD,Deficiency, Glucose-6-Phosphate Dehydrogenase,Dehydrogenase Deficiencies, Glucose-6-Phosphate,Dehydrogenase Deficiencies, Glucosephosphate,Dehydrogenase Deficiency, Glucose-6-Phosphate,Dehydrogenase Deficiency, Glucosephosphate,G6PD Deficiencies,GPD Deficiencies,Glucose-6-Phosphate Dehydrogenase Deficiencies
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F Tzortzatou-Stathopoulou, and L Zannos-Mariolea, and P Karayiannis, and N Constantsas, and N Matsaniotis
October 1985, Proceedings of the National Science Council, Republic of China. Part B, Life sciences,
F Tzortzatou-Stathopoulou, and L Zannos-Mariolea, and P Karayiannis, and N Constantsas, and N Matsaniotis
June 1966, The Journal of clinical investigation,
F Tzortzatou-Stathopoulou, and L Zannos-Mariolea, and P Karayiannis, and N Constantsas, and N Matsaniotis
August 1963, Maryland state medical journal,
F Tzortzatou-Stathopoulou, and L Zannos-Mariolea, and P Karayiannis, and N Constantsas, and N Matsaniotis
November 1967, Metabolism: clinical and experimental,
F Tzortzatou-Stathopoulou, and L Zannos-Mariolea, and P Karayiannis, and N Constantsas, and N Matsaniotis
January 1973, Nihon Naibunpi Gakkai zasshi,
F Tzortzatou-Stathopoulou, and L Zannos-Mariolea, and P Karayiannis, and N Constantsas, and N Matsaniotis
January 2003, Blood cells, molecules & diseases,
F Tzortzatou-Stathopoulou, and L Zannos-Mariolea, and P Karayiannis, and N Constantsas, and N Matsaniotis
June 2003, Annals of general hospital psychiatry,
F Tzortzatou-Stathopoulou, and L Zannos-Mariolea, and P Karayiannis, and N Constantsas, and N Matsaniotis
December 1973, La Nouvelle presse medicale,
F Tzortzatou-Stathopoulou, and L Zannos-Mariolea, and P Karayiannis, and N Constantsas, and N Matsaniotis
December 1967, Indian journal of medical sciences,
F Tzortzatou-Stathopoulou, and L Zannos-Mariolea, and P Karayiannis, and N Constantsas, and N Matsaniotis
January 1964, Bulletin of the World Health Organization,
Copied contents to your clipboard!